fashion -WSS

fashion

author：hotspot 2025-09-04 22:03:22 - browse：9246

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Alabama hospital puts IVF treatments on hold

WSS

With competition flaring, obesity drug hits goal in liver disease study

A public scorecard can help hold safety

Medicare to cover more brain scans for Alzheimer’s patients

WHO calls for emergency meeting on new China virus, as cases spread

Alabama IVF ruling threatens families facing fatal genetic disease

A public scorecard can help hold safety

explore

fashion

focus

What does generative AI mean for health care? We asked experts

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NIH study of ME/CFS points to clear biological hallmarks

After affirmative action ruling, medical educators look to 'holistic review'

Listen: Wegovy in the brain & pivotal Alzheimer's data

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Virtual Event: The State of Biosimilars: What to Watch

Tori Bowie and the unacceptable rates of Black maternal death

How dance can help nurses traumatized by Covid

Wikipedia

NIH study of ME/CFS points to clear biological hallmarks

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Medicare to cover more brain scans for Alzheimer’s patients

Biden tests positive for Covid

In utero gene editing: an explainer

Why hospitals are withdrawing from US News rankings

knowledge

focus

hotspot

focus